POAI POAI

Predictive Oncology Stock Price

0.445
-0.045 (-9.18%)
Upgrade to Real-Time
Afterhours (Closed)
0.445
Volume 335,754
Bid Price 0.441
Ask Price 0.4444
News -
Day High 0.49

Low
0.2486

52 Week Range

High
1.4662

Day Low 0.44
Company Name Stock Ticker Symbol Market Type
Predictive Oncology Inc POAI NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.045 -9.18% 0.445 19:54:31
Open Price Low Price High Price Close Price Prev Close
0.49 0.44 0.49 0.4451 0.49
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
677 335,754 $ 0.4592569 $ 154,197 - 0.2486 - 1.4662
Last Trade Time Type Quantity Stock Price Currency
19:51:10 4 $ 0.445 USD

Period:

Draw Mode:

Predictive Oncology Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 6.86M 15.42M 75.69M $ 1.42M $ - -0.37 -1.50
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - 610.19k 7.50%

more financials information »

Predictive Oncology News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical POAI Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.430.4949710.420.4603117281,0380.0153.49%
1 Month0.4280.4949710.3850.4330286211,8880.0173.97%
3 Months0.3290.63180.24860.3810828910,7630.11635.26%
6 Months0.76621.100.24860.4830787701,225-0.3212-41.92%
1 Year1.071.46620.24860.9030993968,060-0.625-58.41%
3 Years0.605.390.24861.241,336,387-0.155-25.83%
5 Years0.5815.390.24861.231,277,155-0.136-23.41%

Predictive Oncology Description

Predictive Oncology Inc functions in the healthcare domain. The firm's reportable segments are Helomics, zPREDICTA, Soluble and Skyline. It derives prime revenue from the Skyline segment which consists of the STREAMWAY System product sales, and TumorGenesis subsidiary (Research and Development) is included within corporate. The STREAMWAY System virtually eliminates staff exposure to blood, irrigation fluid, and other potentially infectious fluids found in the healthcare environment. Its Helomics division is focused on improving the effectiveness of cancer therapy using proprietary, multi-omic tumor profiling platform, a one-of-a-kind database of historical tumor data, and the power of AI to build predictive models of tumor drug response.


Your Recent History
NASDAQ
POAI
Predictive..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now